Sarasin & Partners LLP, a registered investment adviser, initiated a new position in CME Group Inc. (NASDAQ:CME) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 1,092,937 shares of the Financial Services company, valued at approximately $298,459,238 as of the filing date.
CME Group Inc.'s stock currently trades at $268.80 with a market capitalization of $98,233,738,576.
